Skip to main content
Log in

One-dose HPV may be a cost-effective option in Uganda

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Reported in international dollars (2011 values), where $I1 = $US1.

Reference

  • Burger EA, et al. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine : 25 May 2018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

One-dose HPV may be a cost-effective option in Uganda. PharmacoEcon Outcomes News 805, 24 (2018). https://doi.org/10.1007/s40274-018-5026-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5026-8

Navigation